Home › Diffuse Large B-Cell Lymphoma › Florida › Jacksonville

Pag-aaral pangklinika para sa Diffuse Large B-Cell Lymphoma sa Jacksonville, FL

9 pag-aaral para sa Diffuse Large B-Cell Lymphoma ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Jacksonville (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)

Nagre-recruitPhase 2

Baptist MD Anderson Cancer Center ( Site 0176), Jacksonville

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT06890884

A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma

Nagre-recruitPhase 3

Mayo Clinic Jacksonville, Jacksonville

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT06091865

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

Nagre-recruitPhase 3

Mayo Clinic Florida, Jacksonville

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT07188558

Study of Acalabrutinib and Rituximab in Untreated Elderly and/or Frail Patients With DLBCL

Nagre-recruitPhase 2

Research Site, Jacksonville

Edad 65 hanggang 99 · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT05952024

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

Nagre-recruitPhase 1/2

Mayo Clinic, Clinical Trials Referral Office, Jacksonville

Edad 13 hanggang 90 · Lahat ng kasarian · Na-update Okt 26, 2026 · NCT06533579

Golcadomide and Rituximab as Bridging Therapy for Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma Before CAR T-cell Therapy

Nagre-recruitPhase 2

Mayo Clinic in Florida, Jacksonville

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 20, 2026 · NCT06834373

A Study of APG-3288 in Relapsed/Refractory Blood Cancers

Nagre-recruitPhase 1

Mayo Clinic, Jacksonville

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 15, 2026 · NCT07424833

A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies

Nagre-recruitPhase 1/2

Mayo Clinic Jacksonville, Jacksonville

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT05006716

B-Cell Activating Factor Receptor (BAFFR)-Based Chimeric Antigen Receptor T-Cells With Fludarabine and Cyclophosphamide Lymphodepletion for the Treatment of Relapsed or Refractory B-cell Hematologic Malignancies

Nagre-recruitPhase 1

Mayo Clinic in Florida, Jacksonville

Edad 18 pataas · Lahat ng kasarian · Na-update Peb 13, 2026 · NCT06191887

Pag-aaral para sa Diffuse Large B-Cell Lymphoma sa ibang lungsod

Iba pang pag-aaral sa Jacksonville

Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.